Fida Biosystems
Maja Wasilczyk is an experienced marketing professional with a strong background in brand management and product marketing within the medical and healthcare sectors. Currently serving as a Marketing Manager at Fida Biosystems since October 2022, Maja has successfully established a comprehensive marketing infrastructure and brand identity through collaboration with colleagues and thorough market analysis. Previously, Maja held the role of Brand Manager for CANNASEN® at CS Medica, where responsibilities included coordinating product management and marketing functions. Maja has also gained valuable insights into the dental and orthodontic industry during an internship at 3Shape, alongside assisting in innovation initiatives at ISS A/S and conducting analytical projects on diversity management at Alstom. Maja holds a Master's degree in Brand and Communication Management and a Bachelor's degree in Business, Language, and Culture, complemented by international experience through an exchange program at Universidad ESAN.
This person is not in any teams
Fida Biosystems
Fida Biosystems offers a new proprietary technology developed for quantification and characterization of proteins and nanoparticles from 0.5 to 1,000 nm Dh, incl. antibodies, liposomes, exosomes, membrane embedded proteins et al. Based on accurate, in-solution, absolute measurements of hydrodynamic radius, the technology provides precise information about Kd, concentration, size, stoichiometry, conformational changes, oligomeric state, immunogenicity, multiple bindings etc. It is characterised by being fast (minutes), requiring very small sample amounts (ul-nl), and being exceptionally tolerant to the sample matrix, incl. plasma, serum, cell lysate, fermentation media etc. Contrary to most other procedures, the methodology is based on binding in homogenous solution; complications related to non-specific surface adsorption and challenging assay development are therefore avoided. I.e. the unique features of the FIDA technology enable characterisation and quantification in native (biorelevant) environments and in-built assay quality control and automation.